Ironwood Pharmaceuticals (IRWD) Amortization - Intangibles (2016 - 2018)

Ironwood Pharmaceuticals has disclosed Amortization - Intangibles across 3 years of filings, most recently posting $1.2 million for Q3 2018.

• Amortization - Intangibles for Q3 2018 came in at $1.2 million, down 38.9% year-over-year; the trailing twelve-month figure through Dec 2018 was $8.1 million (up 30.53% YoY), and the FY2018 annual result was $8.1 million, up 30.53% from the prior year.
• Amortization - Intangibles came in at $1.2 million for Q3 2018 at Ironwood Pharmaceuticals, down from $3.5 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $3.5 million in Q4 2017 to a low of $420000.0 in Q1 2017.
• The 3-year median for Amortization - Intangibles is $2.5 million (2016), against an average of $2.2 million.
• Across the five-year window, Amortization - Intangibles slumped 60.47% in 2017 and jumped 727.62% in 2018, its largest moves.
• Ironwood Pharmaceuticals' Amortization - Intangibles stood at $3.3 million in 2016, then climbed by 5.33% to $3.5 million in 2017, then slumped by 66.66% to $1.2 million in 2018.
• The last three Amortization - Intangibles figures came in at $1.2 million (Q3 2018), $3.5 million (Q2 2018), and $3.5 million (Q1 2018), per Business Quant data.